戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  woman had a 2-year history of dyspepsia and lactose intolerance.
2 k allergy must be distinguished from primary lactose intolerance.
3 he level of lactose and to avoid symptoms of lactose intolerance.
4  foods than did those without self-perceived lactose intolerance.
5 n 12 g, is effective in reducing symptoms of lactose intolerance.
6 plements dedicated for people suffering from lactose intolerance.
7 n 24 of 42 subjects (57%) with self-reported lactose intolerance.
8 ologic factors play a role in perceptions of lactose intolerance.
9 derlying flatulence that is misattributed to lactose intolerance.
10 e patients with IBS have symptoms related to lactose intolerance.
11 not significantly related to the presence of lactose intolerance.
12 erly population having swallowing issues and lactose intolerance.
13 ed by individuals with celiac disease and/or lactose intolerance.
14  lactose maldigestion and, in certain cases, lactose intolerance.
15 ncluded in the diet of people suffering from lactose intolerance.
16 tolerant (S-LNP), 13 LNP subjects who denied lactose intolerance (A-LNP), and 10 lactase-persistent i
17 se African Americans are more likely to have lactose intolerance and avoid dairy products, the observ
18 tion of these products is limited due to the lactose intolerance and costs.
19  understand the prevalence of self-perceived lactose intolerance and how it relates to calcium intake
20    We studied 42 subjects with self-reported lactose intolerance and performed breath-hydrogen tests
21 its application to yogurt, use of yogurt for lactose intolerance, and the cost-effectiveness of yogur
22 was to examine the effects of self-perceived lactose intolerance as it relates to calcium intake and
23          The relation between self-perceived lactose intolerance, calcium intakes, and physician-diag
24 rtain gastrointestinal conditions, including lactose intolerance, constipation, diarrheal diseases, c
25         Celiac disease, microscopic colitis, lactose intolerance, early stage Crohn's disease, and bi
26              Respondents with self-perceived lactose intolerance had significantly lower (P < 0.05) a
27 hether an increase in FC could be related to lactose intolerance in patients with IBS.
28 npersister genotype, which typically confers lactose intolerance, in several different human populati
29 ies, short stature, osteopenic bone disease, lactose intolerance, infertility, and nonspecific abdomi
30                                              Lactose intolerance is a major concern driving the growt
31                                              Lactose intolerance is capable of preventing the achieve
32                                              Lactose intolerance is overreported in subjects with gas
33                                              Lactose intolerance is the decreased ability to digest l
34                                              Lactose intolerance is the most common disorder of intes
35                      The primary solution to lactose intolerance is withdrawing lactose from the diet
36  Nowadays irritable bowel syndrome (IBS) and lactose intolerance (LI) are two very frequent diseases.
37                               Self-perceived lactose intolerance may result in adverse dietary modifi
38               Most individuals with presumed lactose intolerance or malabsorption can tolerate 12 to
39 e than of respondents without self-perceived lactose intolerance reported having physician-diagnosed
40                                              Lactose intolerance resulting in gastrointestinal sympto
41 actose ingestion and this adaptation reduces lactose intolerance symptoms.
42 ercentage of respondents with self-perceived lactose intolerance than of respondents without self-per
43  represent an adaptive microbial response to lactose intolerance, thus, it could potentially be mitig
44 are needed to determine the effectiveness of lactose intolerance treatment.
45 he age-adjusted prevalence of self-perceived lactose intolerance was 7.8% for non-Hispanic whites, 20
46 r Omega, were performed in participants with lactose intolerance, where 2 x 1012 CFUs Bi-07, 4662 FCC
47 as also added in the formulation to mitigate lactose intolerance while LHSMP was also exploited as a